Targeting of NSCLC in 2011 by Alice Shaw, MD, PhD
6 Tampilan
• 07/30/23
0
0
Menanamkan
administrator
Pelanggan
Dr. Shaw describes the current data supporting the use of EGFR and ALK targeted therapies in treating molecularly genotyped patients with advanced NSCLC at the 2011 Chabner Colloquium.
Menampilkan lebih banyak
Komentar Facebook
SORT BY-
Komentar Teratas
-
komentar terbaru